0000897069-24-000229.txt : 20240131
0000897069-24-000229.hdr.sgml : 20240131
20240131163740
ACCESSION NUMBER: 0000897069-24-000229
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240130
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ng George K
CENTRAL INDEX KEY: 0001638744
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39531
FILM NUMBER: 24583487
MAIL ADDRESS:
STREET 1: C/O SORRENTO THERAPEUTICS, INC.
STREET 2: 6042 CORNERSTONE COURT WEST, SUITE B
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001533743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 451539785
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
BUSINESS PHONE: 443-776-3133
MAIL ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
FORMER COMPANY:
FORMER CONFORMED NAME: Heatwurx, Inc.
DATE OF NAME CHANGE: 20111028
4
1
form4.xml
X0508
4
2024-01-30
0001533743
Processa Pharmaceuticals, Inc.
PCSA
0001638744
Ng George K
C/O PROCESSA PHARMACEUTICALS, INC.
7380 COCA COLA DRIVE, SUITE 106
HANOVER
MD
21076
true
true
Chief Executive Officer
false
Common Stock
2024-01-30
4
P
0
10000
2.7
A
20000
I
By Family Trust
Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Reflects that shares previously reported as directly held by the reporting person were held in a trust.
/s/ George Ng, by Neda A. Sharifi, as Attorney-in-Fact
2024-01-31